J. R. Parratt

7.1k total citations
169 papers, 4.5k citations indexed

About

J. R. Parratt is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, J. R. Parratt has authored 169 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 49 papers in Pathology and Forensic Medicine and 35 papers in Molecular Biology. Recurrent topics in J. R. Parratt's work include Cardiac Ischemia and Reperfusion (49 papers), Cardiac electrophysiology and arrhythmias (46 papers) and Cardiac Imaging and Diagnostics (30 papers). J. R. Parratt is often cited by papers focused on Cardiac Ischemia and Reperfusion (49 papers), Cardiac electrophysiology and arrhythmias (46 papers) and Cardiac Imaging and Diagnostics (30 papers). J. R. Parratt collaborates with scholars based in United Kingdom, Hungary and Canada. J. R. Parratt's co-authors include G.B. West, Richard Marshall, Á Végh, Susan J. Coker, Kathleen A. Kane, I. McA. Ledingham, I. J. Zeitlin, Cherry L. Wainwright, Gillian A. Gray and J. Grayson and has published in prestigious journals such as Nature, The Lancet and The Journal of Physiology.

In The Last Decade

J. R. Parratt

166 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. R. Parratt United Kingdom 38 1.7k 1.5k 1.0k 972 670 169 4.5k
Kevin Mullane United States 39 995 0.6× 1.4k 1.0× 1.3k 1.3× 1.3k 1.3× 448 0.7× 90 5.4k
Amanda Lochner South Africa 39 1.5k 0.9× 1.6k 1.1× 1.8k 1.8× 1.2k 1.3× 628 0.9× 187 5.3k
Galen M. Pieper United States 39 1.5k 0.9× 995 0.7× 981 1.0× 2.3k 2.3× 339 0.5× 134 4.9k
Tsunehiko Kuzuya Japan 37 1.9k 1.1× 1.2k 0.8× 1.7k 1.7× 805 0.8× 576 0.9× 101 4.5k
Morris Karmazyn Canada 51 2.9k 1.7× 1.9k 1.3× 4.2k 4.2× 1.7k 1.7× 580 0.9× 188 7.9k
Alexander S. Clanachan Canada 36 1.5k 0.9× 1.1k 0.8× 1.7k 1.6× 720 0.7× 428 0.6× 131 4.1k
Charles E. Ganote United States 38 2.4k 1.4× 2.5k 1.7× 1.9k 1.8× 549 0.6× 1.0k 1.5× 82 5.9k
S. Jamal Mustafa United States 38 1.1k 0.6× 514 0.4× 1.2k 1.2× 1.5k 1.6× 139 0.2× 170 4.5k
Ray A. Olsson United States 37 1.2k 0.7× 700 0.5× 1.7k 1.7× 716 0.7× 333 0.5× 116 4.7k
Lei Xi United States 37 1.2k 0.7× 1.2k 0.8× 1.6k 1.6× 1.0k 1.1× 489 0.7× 97 4.3k

Countries citing papers authored by J. R. Parratt

Since Specialization
Citations

This map shows the geographic impact of J. R. Parratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. R. Parratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. R. Parratt more than expected).

Fields of papers citing papers by J. R. Parratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. R. Parratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. R. Parratt. The network helps show where J. R. Parratt may publish in the future.

Co-authorship network of co-authors of J. R. Parratt

This figure shows the co-authorship network connecting the top 25 collaborators of J. R. Parratt. A scholar is included among the top collaborators of J. R. Parratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. R. Parratt. J. R. Parratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Parratt, J. R.. (1998). Nitric oxide in sepsis and endotoxaemia. Journal of Antimicrobial Chemotherapy. 41(suppl 1). 31–39. 98 indexed citations
3.
Parratt, J. R.. (1995). Delayed protection of the heart against ischaemia. Trends in Pharmacological Sciences. 16(10). 351–355. 45 indexed citations
4.
Parratt, J. R.. (1994). Cardioprotection by angiotensin converting enzyme inhibitors - the experimental evidence. Cardiovascular Research. 28(2). 183–189. 38 indexed citations
5.
Wainwright, Cherry L., J. R. Parratt, & Herman Van Belle. (1993). The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs. British Journal of Pharmacology. 109(2). 592–599. 26 indexed citations
6.
Kane, Kathleen A., et al.. (1984). The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion‐induced arrhythmias in anaesthetized rats. British Journal of Pharmacology. 83(1). 299–304. 29 indexed citations
7.
Williams, Frank, Kathleen A. Kane, & J. R. Parratt. (1984). The antiarrhythmic activity of ICS 205–930, an antagonist at peripheral neuronal 5-hydroxytryptamine (5-HT) receptors. Journal of Molecular and Cellular Cardiology. 16. 45–45. 12 indexed citations
8.
Kane, Kathleen A., J. R. Parratt, & Frances M. K. Williams. (1984). An investigation into the characteristics of reperfusion‐induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. British Journal of Pharmacology. 82(2). 349–357. 69 indexed citations
9.
Furman, B L, et al.. (1980). BLOCKADE OF ADRENALINE‐INDUCED HYPERGLYCAEMIA IN THE ANAESTHETIZED CAT BY CONTINUOUS INFUSION OF PHENTOLAMINE AND PROPRANOLOL. British Journal of Pharmacology. 68(3). 461–466. 6 indexed citations
10.
Parratt, J. R., et al.. (1977). FELINE ENDOTOXIN SHOCK: EFFECTS OF METHYLPREDNISOLONE ON KININOGEN‐DEPLETION, ON THE PULMONARY CIRCULATION AND ON SURVIVAL. British Journal of Pharmacology. 60(3). 471–476. 11 indexed citations
11.
Parratt, J. R., et al.. (1975). Proceedings: The protective effect of sodium meclofenamate in experimental endotoxin shock.. British Journal of Pharmacology. 53(3). 466. 1 indexed citations
12.
Marshall, Richard & J. R. Parratt. (1974). Reduction in ventricular arrhythmias following acute coronary artery ligation in the dog after the administration of creatine phosphate. Naunyn-Schmiedeberg s Archives of Pharmacology. 281(4). 437–441. 25 indexed citations
13.
Marshall, Richard, J. R. Parratt, & I. McA. Ledingham. (1974). Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovascular Research. 8(2). 204–215. 46 indexed citations
14.
Hutton, I., J. R. Parratt, & T. D. V. Lawrie. (1973). Cardiovascular effects of prostaglandin E1 in experimental myocardial infarction. Cardiovascular Research. 7(2). 149–155. 23 indexed citations
15.
Parratt, J. R. & E. Winslow. (1972). Haemodynamic and coronary effects of quazodine in cats with developing myocardial infarcts. Journal of Pharmacy and Pharmacology. 24(9). 673–680. 4 indexed citations
16.
Parratt, J. R. & E. Winslow. (1971). The effects of quazodine on myocardial blood flow in developing myocardial infarcts. Journal of Pharmacy and Pharmacology. 23(Supplement_1). 224S–225S. 1 indexed citations
17.
18.
Parratt, J. R. & J. Grayson. (1966). MYOCARDIAL VASCULAR REACTIVITY AFTER BETA-ADRENERGIC BLOCKADE. The Lancet. 287(7433). 338–340. 61 indexed citations
19.
Parratt, J. R., et al.. (1966). URINARY EXCRETION OF 5-HYDROXY-INDOLEACETIC ACID IN NIGERIANS WITH ENDOMYOCARDIAL FIBROSIS. The Lancet. 287(7442). 854–856. 9 indexed citations
20.
Parratt, J. R. & G.B. West. (1960). Hypersensitivity and the Thyroid Gland. International Archives of Allergy and Immunology. 16(5). 288–302. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026